Our client held the global rights to an innovative in-vivo dosimetry technology designed to measure radiation dose directly at the patient’s skin during radiotherapy and invasive radiology procedures.
The solution enables real-time measurement of radiation dose at skin depth without interfering with the radiation field, offering the potential to improve treatment monitoring and patient safety.
As the client prepared to launch a new specialist dosimetry system based on this technology, they needed to better understand the market opportunity, adoption potential, and optimal portfolio positioning.
Although in-vivo dosimetry was already used in some radiotherapy procedures, adoption remained inconsistent and clinical practices varied across institutions and geographies. The client therefore required a clearer understanding of clinical workflows, technology use, adoption drivers, and the overall size and structure of the opportunity to inform their launch strategy and future product roadmap.
Key questions included:
-How is in-vivo dosimetry currently used within radiotherapy and interventional radiology workflows?
-Which technologies are used today and how are they perceived by clinicians?
-What clinical, operational, and reimbursement factors influence adoption?
-What is the current and future market opportunity for in-vivo dosimetry solutions?
-How should the new system be positioned within the broader dosimetry portfolio?
1. Market Landscape & Technology Assessment
We analysed the landscape of in-vivo dosimetry technologies, including commonly used solutions such as MOSFET sensors, thermoluminescent dosimeters, and diode detectors.
This phase focused on understanding:
-Current standard operating procedures for radiation dose monitoring
-How technologies are used across clinical settings
-Competitive positioning and emerging trends in radiation safety
2. Clinical Workflow Market Research
We conducted research with clinicians involved in radiotherapy and interventional radiology procedures to understand how dosimetry technologies are integrated into real-world workflows.
This allowed us to map:
-Clinical workflows around radiation dose monitoring
-The role of different healthcare professionals in the dosimetry process
-Situations where in-vivo dosimetry delivers the greatest clinical value
3. Market Sizing & Strategic Opportunity Assessment
We quantified the potential market opportunity by assessing:
-The proportion of procedures where in-vivo dosimetry is currently used
-Potential expansion opportunities across clinical applications
-Historic and forecast market growth
These insights were used to identify priority applications and segments for launch and inform portfolio planning for future product development.
The project delivered a strategic foundation for portfolio planning and market entry, including:
-Analysis of current clinical workflows and dosimetry practices
-Competitive landscape and technology positioning
-Identification of key adoption drivers and barriers
-Assessment of the reimbursement environment and its impact on uptake
-Quantification of current market size and future growth potential
-Identification of priority clinical applications and launch segments
The research provided the client with a clear understanding of the role of in-vivo dosimetry within radiotherapy and interventional radiology workflows, and where new technologies could deliver the greatest value.
By quantifying the market opportunity and identifying priority use cases, we helped the client define how to position the new device within their broader dosimetry portfolio.
The insights directly informed the client’s launch strategy, target market prioritisation, and product roadmap, enabling them to focus development and commercial resources on the segments with the greatest potential for adoption and growth.